Avent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVENT, and what generic and branded alternatives to AVENT drugs are available?
AVENT has one approved drug.
Summary for Avent
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 1 |
| PTAB Cases with Avent as patent owner: | See PTAB cases with Avent as patent owner |
Drugs and US Patents for Avent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avent | PYTEST KIT | urea, c-14 | CAPSULE;ORAL | 020617-002 | May 9, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avent | PYTEST | urea, c-14 | CAPSULE;ORAL | 020617-001 | May 9, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Avent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Avent | PYTEST | urea, c-14 | CAPSULE;ORAL | 020617-001 | May 9, 1997 | 4,830,010 | ⤷ Sign Up |
| Avent | PYTEST KIT | urea, c-14 | CAPSULE;ORAL | 020617-002 | May 9, 1997 | 4,830,010 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
